Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001580059 | SCV003246262 | benign | not provided | 2024-12-23 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001580059 | SCV005188585 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Genome Diagnostics Laboratory, |
RCV001580059 | SCV001809525 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001580059 | SCV001965636 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003910907 | SCV004722803 | likely benign | FNIP1-related disorder | 2022-02-17 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |